Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
During the past 12 months, Acutaas Chemicals's average EBITDA Per Share Growth Rate was 74.60% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was 25.40% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 29.50% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 7 years, the highest 3-Year average EBITDA Per Share Growth Rate of Acutaas Chemicals was 42.70% per year. The lowest was 8.40% per year. And the median was 32.45% per year.
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.
Acutaas Chemicals 5-Year EBITDA Growth Rate Related Terms
NSE:ACUTAAS vs LIN, SHW, ECL: 5-Year EBITDA Growth Rate Comparison
For the Specialty Chemicals subindustry, Acutaas Chemicals's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Acutaas Chemicals 5-Year EBITDA Growth Rate vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Acutaas Chemicals's 5-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Acutaas Chemicals's 5-Year EBITDA Growth Rate falls into.
This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 5-Year EBITDA Growth Rate of 29.50% mean?
Acutaas Chemicals (NSE:ACUTAAS) has a 5-Year EBITDA Growth Rate of 29.50% as of Jun. 2026. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Acutaas Chemicals and its competitors.
Is Acutaas Chemicals' 5-Year EBITDA Growth Rate too high?
Acutaas Chemicals' current 5-Year EBITDA Growth Rate is 29.50%. Overall, Acutaas Chemicals has a GF Score™ of 72/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Acutaas Chemicals' 5-Year EBITDA Growth Rate compare to LIN and SHW?
Acutaas Chemicals' 5-Year EBITDA Growth Rate of 29.50% can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year EBITDA Growth Rate for a Chemicals company?
A good 5-Year EBITDA Growth Rate depends on the Chemicals industry context. However, 5-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year EBITDA Growth Rate mean?
A high 5-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Acutaas Chemicals and its competitors. Acutaas Chemicals's current 5-Year EBITDA Growth Rate is 29.50%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Acutaas Chemicals stock overvalued right now?
Based on GuruFocus' analysis, Acutaas Chemicals (NSE:ACUTAAS) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹1,386.19, compared to a current price of ₹3,281.60 — trading 136.7% above its estimated fair value. The current 5-Year EBITDA Growth Rate is 29.50%. Acutaas Chemicals' overall GF Score™ is 72/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year EBITDA Growth Rate calculated?
5-Year EBITDA Growth Rate is calculated from a company's financial statements. For Acutaas Chemicals (NSE:ACUTAAS), the current 5-Year EBITDA Growth Rate is 29.50% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Acutaas Chemicals (NSE:ACUTAAS) Overvalued in 2026?
Based on GuruFocus' analysis, Acutaas Chemicals stock appears to be overvalued.
The current stock price of ₹3,281.60 is trading 136.7% above its estimated GF Value™ of ₹1,386.19.
GuruFocus considers Acutaas Chemicals to be Significantly Overvalued.
Key valuation signals for NSE:ACUTAAS:
5-Year EBITDA Growth Rate: 29.50%
GF Value™: ₹1,386.19 vs. price of ₹3,281.60 (136.7% above fair value)
No single metric tells the full story. See the NSE:ACUTAAS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Acutaas Chemicals Ltd is principally engaged in the business of drugs intermediate chemicals and related activities. It manufactures different types of pharmaceutical intermediates and active pharmaceutical ingredients, specialty chemicals, and formulations. Its products are used in various industrial sectors, including Pharmaceutical, Personal Care, Cosmetics, Dyes, Polymers, Agro Chemicals, and Animal Foods industries. The company caters to both domestic and international markets and generates the majority of its revenue from outside India.
72GF Score
Get the complete analysis for NSE:ACUTAAS
5-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ACUTAAS has been successfully added to your 
